Subscribe to Newsletter

How to improve performance of the Protein A capturing step

Introduction

Protein A has become a well-established platform for capturing of monoclonal antibodies and Fc-fusion proteins. Various Protein A resins have been commercialized, one with a higher dynamic binding capacity than the other. Especially the latest generation of Protein A resins was developed to bind large quantities of mAbs and Fc fusion proteins. One drawback of these resins is that host cell protein (HCP) clearance can be - depending on the feedstream - comparatively lower than for standard Protein A affinity resins. When aiming for a 2-step platform process, no compromises can be made with regards to HCP removal of the capturing step.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register